Changes in tear volume and ocular symptoms of patients receiving oral anticancer drug S-1

BACKGROUND: Most eye disorders are not fatal but may deteriorate the quality of life of a patient. The eye disorder that is most frequently reported in the cancer chemotherapy is associated with the combination of tegafur/gimeracil/potassium oxonate (S-1). However, preventive methods or treatment me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuriki, Reiko, Hata, Tsuyoshi, Nakayama, Kinuyo, Ito, Yuichi, Misawa, Kazunari, Ito, Seiji, Tatematsu, Michiko, Kaneda, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803866/
https://www.ncbi.nlm.nih.gov/pubmed/29445512
http://dx.doi.org/10.1186/s40780-018-0100-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803866/
https://www.ncbi.nlm.nih.gov/pubmed/29445512
http://dx.doi.org/10.1186/s40780-018-0100-8

Ejemplares similares